A
Aardvark Therapeutics, Inc.
$1.40
Mkt Cap 30.5M
Clinical-stage biopharmaceutical company developing small-molecule drugs designed to inhibit hunger and treat metabolic disease; no approved products yet.
aardvarktherapeutics.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
Running full 6-factor analysis…